161 related articles for article (PubMed ID: 30149147)
1. Risk Factors for Parainfluenza Virus Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation.
Seo S; Xie H; Leisenring WM; Kuypers JM; Sahoo FT; Goyal S; Kimball LE; Campbell AP; Jerome KR; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2019 Jan; 25(1):163-171. PubMed ID: 30149147
[TBL] [Abstract][Full Text] [Related]
2. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome.
Seo S; Xie H; Campbell AP; Kuypers JM; Leisenring WM; Englund JA; Boeckh M
Clin Infect Dis; 2014 May; 58(10):1357-68. PubMed ID: 24599766
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
[TBL] [Abstract][Full Text] [Related]
5. Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
Piñana JL; Tridello G; Xhaard A; Wendel L; Montoro J; Vazquez L; Heras I; Ljungman P; Mikulska M; Salmenniemi U; Perez A; Kröger N; Cornelissen J; Sala E; Martino R; Geurten C; Byrne J; Maertens J; Kerre T; Martin M; Pascual MJ; Yeshurun M; Finke J; Groll AH; Shaw PJ; Blijlevens N; Arcese W; Ganser A; Suarez-Lledo M; Alzahrani M; Choi G; Forcade E; Paviglianiti A; Solano C; Wachowiak J; Zuckerman T; Bader P; Clausen J; Mayer J; Schroyens W; Metafuni E; Knelange N; Averbuch D; de la Camara R
J Infect Dis; 2024 Jan; 229(1):83-94. PubMed ID: 37440459
[TBL] [Abstract][Full Text] [Related]
6. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
Nichols WG; Corey L; Gooley T; Davis C; Boeckh M
Blood; 2001 Aug; 98(3):573-8. PubMed ID: 11468152
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.
Ogimi C; Waghmare AA; Kuypers JM; Xie H; Yeung CC; Leisenring WM; Seo S; Choi SM; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2017 Jun; 64(11):1532-1539. PubMed ID: 28329354
[TBL] [Abstract][Full Text] [Related]
8. Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.
Ustun C; Slabý J; Shanley RM; Vydra J; Smith AR; Wagner JE; Weisdorf DJ; Young JA
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1580-8. PubMed ID: 22531491
[TBL] [Abstract][Full Text] [Related]
9. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Piñana JL; Xhaard A; Tridello G; Passweg J; Kozijn A; Polverelli N; Heras I; Perez A; Sanz J; Berghuis D; Vázquez L; Suárez-Lledó M; Itäla-Remes M; Ozcelik T; Iturrate Basarán I; Karakukcu M; Al Zahrani M; Choi G; Cuesta Casas MA; Batlle Massana M; Viviana A; Blijlevens N; Ganser A; Kuskonmaz B; Labussière-Wallet H; Shaw PJ; Yegin ZA; González-Vicent M; Rocha V; Ferster A; Knelange N; Navarro D; Mikulska M; de la Camara R; Styczynski J
J Infect Dis; 2021 May; 223(9):1564-1575. PubMed ID: 32860509
[TBL] [Abstract][Full Text] [Related]
10. Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy.
Lee J; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
Ann Hematol; 2020 Jun; 99(6):1231-1239. PubMed ID: 32382770
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
12. DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center.
Salvatore M; Satlin MJ; Jacobs SE; Jenkins SG; Schuetz AN; Moss RB; Van Besien K; Shore T; Soave R
Biol Blood Marrow Transplant; 2016 May; 22(5):965-70. PubMed ID: 26904972
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.
Piñana JL; Gómez MD; Pérez A; Madrid S; Balaguer-Roselló A; Giménez E; Montoro J; González EM; Vinuesa V; Moles P; Hernández-Boluda JC; Salavert M; Calabuig M; Sanz G; Solano C; Sanz J; Navarro D
Transpl Infect Dis; 2018 Aug; 20(4):e12926. PubMed ID: 29809298
[TBL] [Abstract][Full Text] [Related]
14. Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy.
Pérez A; Montoro J; Chorão P; Gómez D; Guerreiro M; Giménez E; Villalba M; Sanz J; Hernani R; Hernández-Boluda JC; Lorenzo I; Navarro D; Solano C; Ljungman P; Piñana JL
Infection; 2024 Apr; ():. PubMed ID: 38653955
[TBL] [Abstract][Full Text] [Related]
15. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152
[TBL] [Abstract][Full Text] [Related]
16. Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality.
Seo S; Waghmare A; Scott EM; Xie H; Kuypers JM; Hackman RC; Campbell AP; Choi SM; Leisenring WM; Jerome KR; Englund JA; Boeckh M
Haematologica; 2017 Jun; 102(6):1120-1130. PubMed ID: 28183847
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State.
Ogimi C; Englund JA; Bradford MC; Qin X; Boeckh M; Waghmare A
J Pediatric Infect Dis Soc; 2019 Mar; 8(1):21-28. PubMed ID: 29447395
[TBL] [Abstract][Full Text] [Related]
18. Human Metapneumovirus Infections Following Hematopoietic Cell Transplantation: Factors Associated With Disease Progression.
Seo S; Gooley TA; Kuypers JM; Stednick Z; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2016 Jul; 63(2):178-85. PubMed ID: 27143659
[TBL] [Abstract][Full Text] [Related]
19. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.
Chemaly RF; Shah DP; Boeckh MJ
Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S344-51. PubMed ID: 25352629
[TBL] [Abstract][Full Text] [Related]
20. Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection.
Waghmare A; Xie H; Kuypers J; Sorror ML; Jerome KR; Englund JA; Boeckh M; Leisenring WM
Biol Blood Marrow Transplant; 2019 May; 25(5):1011-1021. PubMed ID: 30537551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
